ACE2 and invasive breast carcinoma: Interestingly, there was no significant relationship between the expressions of ACE2 and the prognosis of breast invasive carcinoma, kidney chromophobe, prostate adenocarcinoma, stomach adenocarcinoma, thyroid carcinoma, colon adenocarcinoma and head and neck squamous cell carcinoma (Supplementary Figure 1A–1G).